First Time Loading...

Accolade Inc
NASDAQ:ACCD

Watchlist Manager
Accolade Inc Logo
Accolade Inc
NASDAQ:ACCD
Watchlist
Price: 7.54 USD 3.86% Market Closed
Updated: May 4, 2024

Accolade Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Accolade Inc
Operating Expenses Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Accolade Inc
NASDAQ:ACCD
Operating Expenses
-$326.9m
CAGR 3-Years
-45%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Operating Expenses
-$2.2B
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
-3%
Quest Diagnostics Inc
NYSE:DGX
Operating Expenses
-$1.8B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
0%
CVS Health Corp
NYSE:CVS
Operating Expenses
-$39.3B
CAGR 3-Years
24%
CAGR 5-Years
-7%
CAGR 10-Years
-10%
Cigna Corp
NYSE:CI
Operating Expenses
-$16.1B
CAGR 3-Years
-1%
CAGR 5-Years
-7%
CAGR 10-Years
6%
Laboratory Corporation of America Holdings
NYSE:LH
Operating Expenses
-$2.3B
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
-7%

See Also

What is Accolade Inc's Operating Expenses?
Operating Expenses
-326.9m USD

Based on the financial report for Feb 28, 2023, Accolade Inc's Operating Expenses amounts to -326.9m USD.

What is Accolade Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-32%

Over the last year, the Operating Expenses growth was -29%. The average annual Operating Expenses growth rates for Accolade Inc have been -45% over the past three years , -32% over the past five years .